Yes, so that is why the company does not know why. That is why no one knew why the partial halt occurred and that it was definitely not for safety. That is why it’s a mystery. That is why the fact that is is a mystery is so telling.
And, as I have explained in the past, had it been for some strange safety reason that has been speculated upon as infinitum in the boards, the regulators would have made that reason known to doctors and the company, probably public, and consent forms would have been likely updated to address such risk. Nothing like that occurred and we know the company has said it was not a safety issue. If it had been, we’d all know about it, and it would not likely have been only a partial halt where mysteriously the placebo arm was contracted, but no one seems to know exactly why, again, because it was never unblinded...
Regulatory matters are not as mysterious as bulletin board posters make them out to be. One just has to have some solid idea of how they actually work, what is likely, what is impossible and what likes up as most likely. That’s my view anyway.
News 
Market Data 
Discover 
